Brian Stewart, our director of news.

And for those that are just checking in for the first time,

Brian and I do a weekly roundup every Friday morning recorded on Thursday afternoons.

Here we are for another week.

Brian, welcome back. Great to be here.

Summarize what we've been seen for the past week. Certainly a lot going on, I would say.

I was thinking we start with United Health. We had a CEO resign. Anybody that's paying attention to the world, I would say, has seen what's going on with United Health a little bit.

But from an investing perspective, what are you seeing from United Health?

Yeah, I think it's interesting to look at the stock narratively.

So starting with the high profile murder of its insurance group head. Moving forward

from there, we saw the company have earnings recently where it missed expectations. This had

this stock going down. And then this week, we had the abrupt departure of its CEO, Andrew

Witty, also withdrew guidance at that point. There were signs in there that the company was

suffering from higher medical care activity and higher medical costs. Basically, its insurance

customers are using medical services more than they

expected, and those services are coming at a higher price than was expected. So that's obviously

cutting into the bottom line. And then the final blow this week has been reports of a DOJ probe

from Medicare fraud by the company.

So the stock is down 32% over the past five days that's going into today and then down another 15% on Thursday on reports of the DOJ probe.

If you're looking at this from kind of a bearish philosophy, you could say this company is in tatters. It's one bad

news after another. If you're looking at from a bullish perspective, the CEO leaving marks kind

of day zero for the new United Health, and they can move forward from here. The DOJ investigation will be what it is,

...